These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20557356)

  • 1. A case report of an acquired inhibitor to coagulation factor V.
    Shanmugam H; Jayaranee S; Eow GI
    Haemophilia; 2011 Jan; 17(1):168-70. PubMed ID: 20557356
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment with intravenous immunoglobulin (IVIg) in a patient with an acquired factor V inhibitor after liver transplantation.
    Guglielmone H; Jarchum G; Minoldo S
    Thromb Haemost; 2011 Nov; 106(5):985-6. PubMed ID: 21901236
    [No Abstract]   [Full Text] [Related]  

  • 3. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
    Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical cases of acquired coagulation inhibitors].
    Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
    Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired factor V inhibitor after haematopoietic stem cell transplantation.
    Milojkovic D; Patel R; Ford E; Arya R; Mufti G
    Thromb Haemost; 2007 Sep; 98(3):685-7. PubMed ID: 17849062
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired factor V inhibitor in a context of sepsis and disseminated intravascular coagulation.
    Tessier-Marteau A; Croquefer S; Meziani F; Cau S; Asfar P; Macchi L
    Am J Hematol; 2010 Feb; 85(2):145-6. PubMed ID: 20052744
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful management of a possible antibiotic-related acquired factor V inhibitor: a case report and review of the literature.
    Motwani P; Howard L; Ali SS
    Acta Haematol; 2013; 129(3):182-4. PubMed ID: 23257771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V inhibitor: case report.
    Leus B; Devreese K; van den Bossche J; Malfait R
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):585-7. PubMed ID: 16988556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acquired inhibitor against coagulation factor V with severe hematuria].
    Hasegawa M; Tanaka T; Kii T; Fujiwara S; Ikeda N; Kinntaka D; Takeuti T; Tanaka H; Ikemoto T
    Rinsho Ketsueki; 2003 Sep; 44(9):933-9. PubMed ID: 14577313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.
    Bomgaars L; Carberry K; Fraser C; West A; Teruya J
    Congenit Heart Dis; 2010; 5(3):303-8. PubMed ID: 20576051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases.
    Li F; Shu K; Liu J; Shen C; Wang X; Zhang Z; Jiang M
    Acta Haematol; 2019; 141(3):148-150. PubMed ID: 30783058
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired factor V inhibitor in a critically ill patient.
    Morris CJ; Curry N
    Anaesthesia; 2009 Sep; 64(9):1014-7. PubMed ID: 19686488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
    Borucki K; Töpfer G; Hartung KJ; Lutze G
    Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors.
    Nakata K; Ueda S; Matsunaga H; Mima F; Ueda H; Yoshioka A; Kaneko S; Maruo K; Morris S; Yonemoto S; Hayashi D; Fujii N; Narahara H; Inui Y; Kawata S
    Intern Med; 2018 Feb; 57(3):393-397. PubMed ID: 29093398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V inhibitor developing after liver transplantation in a 3-year-old child.
    Gordon B; Haire W; Duggan M; Langnas A; Shaw B
    Pediatrics; 1991 Jul; 88(1):156-9. PubMed ID: 2057253
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
    Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
    Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An acquired factor V inhibitor: clinical and laboratory features.
    Shastri KA; Ho C; Logue G
    J Med; 1999; 30(5-6):357-66. PubMed ID: 10851568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acquired factor V inhibitor treated with intravenous immunoglobulins].
    Buclin T; Schmidt PM; Hauert J; Winkel L; Chapuis G; Bachmann F
    Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1968-70. PubMed ID: 1475662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired inhibitors of factor V.
    Feinstein DI
    Thromb Haemost; 1978 Jun; 39(3):663-74. PubMed ID: 705695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.